Research
Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease.
Latest stories
Clinical Trials
October 2, 2024
Research
Mayo Clinic secures ARPA-H award to build a living pharmacy within the body for inflammatory disease
October 2, 2024
Research
September 30, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community